Mitochondrial Replacement Techniques:
EXPLORING THE ETHICS
At the request of the U.S. Food and Drug Administration (FDA), the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine published a report that looks at the ethical, social, and policy issues surrounding mitochondrial replacement techniques (MRT) to prevent the transmission of mitochondrial DNA disease from mother to child.
To learn more about mitochondrial replacement techniques and the report, click on the menu (top right) to view a list of frequently asked questions, or click the question (below) to get started.
What are mitochondrial DNA diseases? ›
‹ Previous
Is there a cure?
neurological problems
developmental delays
vision problems
cardiovascular
problems
kidney failure
muscle weakness, fatigue,
and exercise intolerance
intestinal problems, including
liver failure
diabetes mellitus
There is no cure or FDA-approved treatment for mitochondrial DNA (mtDNA) disease, which can result in debilitating illness or premature death in infants and children.
Common symptoms can include:
What is MRT? ›
02
‹ Previous
Hover over each step of the mitochondrial replacement technique (maternal spindle transfer pictured here) for additional information.
How does it work?
Would these children have three parents? ›
04
‹ Previous
Would these children have three parents?
Children born as a result of MRT would have genetic material from three individuals—nuclear DNA from each of the intended parents and mitochondrial DNA from a second woman (the oocyte provider). For intended parents and oocyte providers participating in an MRT clinical investigation, there would need to be discussion and agreement during the informed consent process about the social involvement, if any, of the oocyte or sperm provider with the future child and his or her family.
Is this germline modification? ›
05
‹ Previous
Why only males?
The committee recommended that initial clinical investigations be limited to the transfer of male embryos. This limitation reduces the risk of any uncertain consequences of MRT from being passed on to future generations since males do not pass down their mitochondrial DNA to offspring. Under certain conditions, as outlined in the report, transfer of female embryos created through MRT could be considered in the future.
Is this genetic engineering? ›
07